Cell Publication Highlights Ionpath MIBI Spatial Proteomics Technology in Foundational Study Predicting Breast Cancer Progression

Via Peters

MENLO PARK, Calif.–(BUSINESS WIRE)–Ionpath, Inc., the leader in high-definition spatial proteomics, today announced that a peer-reviewed research study led by scientists at Stanford University, Washington University, Duke University, and Arizona State University has been published in the journal Cell. The study, which focused on investigating potential indicators in the progression […]

Single-Cell Spatial Analysis for Immunotherapy Response Prediction in Early TNBC Shows Promise

Via Peters

Imaging mass cytometry at the single-cell level showed potential as an immunotherapy response prediction tool in early triple-negative breast cancer. Benefits of adding atezolizumab (Tecentriq) to neoadjuvant chemotherapy in patients with high-risk early and locally advanced triple-negative breast cancer (TNBC) was possible to determine with imaging mass cytometry (IMC) for […]